Product Images Folic Acid

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Folic Acid NDC 72241-050 by Modavar Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

folicacid-struc - folicacid struc

folicacid-struc - folicacid struc

modavar-cont-label-100-count - modavar cont label 100 count

modavar-cont-label-100-count - modavar cont label 100 count

Description: This is a description of Folic Acid tablets, USP, with each tablet containing 1mg of Folc Acid. The tablets are prescribed for use and the complete prescribing information can be found in the accompanying literature. The contents should be dispensed in a child-resistant container and stored in a tight, light-resistant container at a temperature of 20° to 25°C. The medication should be protected from light and moisture and kept out of reach of children. The tablets are manufactured by Catila Pharmaceuticals Limited in India, and they are distributed by Modavar Pharmaceuticals LLG in Washington, DC. The expiration date of the tablets is 12/2023.*

modavar-cont-label-1000-count - modavar cont label 1000 count

modavar-cont-label-1000-count - modavar cont label 1000 count

Description: This is a description for a medication called Folic Acid Tablets, USP. Each tablet contains 1mg of Folic Acid. The appropriate dosage and complete prescribing information can be found in the accompanying material. The medication should be dispensed with a child-resistant closure and stored in a tightly sealed container as defined by the USP. It should be stored at a temperature of 68 to 77 degrees Fahrenheit, protected from light and moisture. It is important to keep this medication and all other medications out of the reach of children. The manufacturer of the medication is Cadila Pharmaceuticals Limited, located in Gujarat, India. The medication was issued on 12/20/23.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.